Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the hypercalcemia treatment market grown over the years?

In recent times, the market size of hypercalcemia treatment has witnessed accelerated growth. The forecasts anticipate an escalation from $16.44 billion in 2024 to $18.34 billion in 2025, showing a compound annual growth rate (CAGR) of 11.5%. Factors contributing to this growth in the historic period include increased understanding of hypercalcemia, a growing older population, a rise in cancer instances, heightened disease awareness, and an increase in occurrences of parathyroid conditions.

What Is the forecasted market size and growth rate for the hypercalcemia treatment market?

Over the coming years, a swift expansion is anticipated in the hypercalcemia treatment market. The market is projected to reach a value of $28.31 billion by 2029, with a CAGR of 11.5%. Several factors contribute to this projected growth, such as the increasing incidence of chronic renal disease, a rise in hypertension cases, more significant investment in the creation of new drugs, growing patient awareness and empowerment, and government policies. Upgrades in diagnostic tools and procedures, progress in treatments, the introduction of innovative treatment drugs, and partnerships among health service providers are notable trends expected to shape the forecasted period.

Get your hypercalcemia treatment market report here!

https://www.thebusinessresearchcompany.com/report/hypercalcemia-treatment-global-market-report

What are the major factors driving growth in the hypercalcemia treatment market?

The hypercalcemia treatment market is expected to gain momentum due to the increasing occurrence of parathyroid disorders. Parathyroid disorders are conditions that impact the parathyroid glands which manage the body’s calcium levels by generating parathyroid hormone (PTH). This increase can be linked to factors like the growing elderly population, heightened awareness, enhanced diagnostic methods, and the escalating occurrence of conditions such as primary hyperparathyroidism and chronic kidney disease. Hypercalcemia treatment plays a vital role in controlling these disorders by managing elevated calcium levels, avoiding kidney stones and bone loss, and enhancing the overall metabolic equilibrium. For example, the US National Institute of Health (NIH) reported in February 2024, that hypoparathyroidism impacts between 6.4 to 37 per 100,000 person-years in the United States, with 75% of these cases resulting from thyroidectomy or head and neck surgery complications. Consequently, the increasing prevalence of parathyroid disorders is fueling the expansion of the hypercalcemia treatment market.

What key areas define the segmentation of the global hypercalcemia treatment Market?

The hypercalcemia treatment market covered in this report is segmented –

1) By Drug Type: Bisphosphonates, Calcitonin, Glucocorticoids, Denosumab, Calcimimetics, Other Drug Types

2) By Indication: Primary Hyperthyroidism, Hypercalcemia Of Malignancy, Other Indications

3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End-Users: Hospitals, Clinics

Subsegments:

1) By Bisphosphonates: Zoledronic Acid, Pamidronate, Alendronate

2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin

3) By Glucocorticoids: Prednisone, Dexamethasone, Hydrocortisone

4) By Denosumab: Denosumab (Monotherapy), Denosumab Combination Therapy

5) By Calcimimetics: Cinacalcet, Etelcalcetide

6) By Other Drug Types: Gallium Nitrate, Mithramycin

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21206&type=smp

What are the top market players propelling the growth of the hypercalcemia treatment industry?

Major companies operating in the hypercalcemia treatment market are Pfizer Inc., Roche Holding AG, AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Amgen Inc., Merck KGaA, Fresenius Medical Care AG & Co. KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen SA, Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals plc, Endo International plc, OPKO Health Inc., Ferring Pharmaceuticals A/S, Rockwell Medical Inc., Strides Pharma Science Limited

What emerging trends are influencing the growth of the hypercalcemia treatment market?

Key players in the hypercalcemia treatment market are concentrating on the creation of novel products such as phosphate binders to optimize the regulation of calcium and phosphorus, thereby enhancing treatment results. Phosphate binders are drugs which attach to phosphate in the digestive system, preventing it from being absorbed into the blood stream. They are typically employed to control heightened phosphate levels in those suffering from kidney disease or hypercalcemia. For example, Strides Pharma Science Limited, an India-based pharmaceutical firm, gained approval from the United States Food and Drug Administration (FDA) in May 2024 for its Sevelamer Carbonate Tablets, 800 mg. By blocking the absorption of dietary phosphate, these tablets effectively manage hyperphosphatemia in patients with chronic kidney disease. Such tablets help preserve bone health and lessen cardiovascular risks related to elevated phosphate levels.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21206

What regions are dominating the hypercalcemia treatment market growth?

North America was the largest region in the hypercalcemia treatment market in 2024. The regions covered in the hypercalcemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Liver Health Supplements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Pharmaceutical Drug Delivery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Drugs for Immunotherapy Global Market Report 2025

https://thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: